First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.89 EUR 3.96% Market Closed
Updated: Apr 24, 2024

Wall Street
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 10.27 EUR with a low forecast of 4.14 EUR and a high forecast of 15.75 EUR.

Lowest
Price Target
4.14 EUR
43% Upside
Average
Price Target
10.27 EUR
255% Upside
Highest
Price Target
15.75 EUR
445% Upside
BRAIN Biotech AG Competitors:
Price Targets
4764
Double Bond Chemical Ind Co Ltd
121% Upside
603659
Shanghai Putailai New Energy Technology Co Ltd
57% Upside
688065
Cathay Biotech Inc
70% Upside
4046
Osaka Soda Co Ltd
30% Upside
4095
Nihon Parkerizing Co Ltd
84% Upside
4966
C.Uyemura & Co Ltd
0% Upside
IOF
Iofina PLC
100% Upside
WCH
Wacker Chemie AG
14% Upside

Revenue
Forecast

Revenue Estimate
BRAIN Biotech AG

For the last 8 years the compound annual growth rate for BRAIN Biotech AG's revenue is 11%. The projected CAGR for the next 3 years is 13%.

11%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
BRAIN Biotech AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
BRAIN Biotech AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNN's stock price target?
Price Target
10.27 EUR

According to Wall Street analysts, the average 1-year price target for BNN is 10.27 EUR with a low forecast of 4.14 EUR and a high forecast of 15.75 EUR.

What is BRAIN Biotech AG's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for BRAIN Biotech AG's revenue is 11%. The projected CAGR for the next 3 years is 13%.